Marking A Year’s Milestones

In 2022, Pfizer continued to strive to enhance shareholder value through development of its innovative R&D pipeline and strategic acquisitions, while maintaining its focus on health equity and environmental stewardship.

As the company looks to build on these initiatives moving forward, here’s a look at some of the key achievements from the past year.

Join Pfizer Investor Insights

Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts.

I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy.